Status:
TERMINATED
Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19
Lead Sponsor:
Baylor College of Medicine
Conditions:
Covid19
Eligibility:
All Genders
55-85 years
Phase:
EARLY_PHASE1
Brief Summary
COVID-19 is associated with increased mortality, and has been linked to a 'cytokine inflammatory storm'. Populations at higher risk of COVID complications and mortality include the elderly, diabetic p...
Detailed Description
This study will investigate associated defects in the following two populations of patients with COVID-19: Hospitalized patients admitted for COVID-19 will sign an informed consent form, and be rando...
Eligibility Criteria
Inclusion
- Age 55-85y;
- Diagnosis of COVID-19;
- Hospitalized patients.
Exclusion
- Active heart disease or active cancer at time of recruitment;
- Patients in Intensive Care Unit at the time of recruitment;
- Patents with alanine transaminase and aspartate transaminase greater than 5 times the upper limit of normal at any time;
- Patients requiring \>4L per minute of oxygen support at the time of recruitment.
Key Trial Info
Start Date :
January 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04703036
Start Date
January 11 2021
End Date
March 31 2023
Last Update
June 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor College of Medicine
Houston, Texas, United States, 77030